secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2022-11-01T23:59:59+00:00
Accession:  0001558370-22-015785
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kala Pharmaceuticals appoints Marjan Farid, M.D. to board of directors
----------------------------------------------------------------------

- Dr. Farid appointed as Class I director effective Oct. 31, 2022; term expires at 2024 annual meeting.
- She joins the Nominating and Corporate Governance Committee.
- Received a one-time stock option to purchase 1,600 shares at $6.35 per share (closing price on appointment date).
- Option vests 1/3 on first anniversary, then monthly over three years; standard indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000155837022015785/0001558370-22-015785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000155837022015785/kala-20221031x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-015785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer